✦ LIBER ✦

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

✍ Scribed by M. Raikou; A. McGuire; H. M. Colhoun; D. J. Betteridge; P. N. Durrington; G. A. Hitman; H. A. W. Neil; S. J. Livingstone; V. Charlton-Menys; J. H. Fuller; CARDS Investigators

Publisher: Springer
Year: 2007
Tongue: English
Weight: 181 KB
Volume: 50
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s00125-006-0561-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rapid emergence of effect of atorvastati

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)

✍ H. M. Colhoun; D. J. Betteridge; P. N. Durrington; G. A. Hitman; H. A. W. Neil; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 103 KB

The course of depressive symptoms in pri

The course of depressive symptoms in primary care patients with type 2 diabetes: results from the Diabetes, Depression, Type D Personality Zuidoost-Brabant (DiaDDZoB) Study

✍ G. Nefs; F. Pouwer; J. Denollet; V. Pop 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 206 KB

Additive effects of glycaemia and dyslip

Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register

✍ S. Gudbjörnsdottir; B. Eliasson; K. Eeg-Olofsson; B. Zethelius; J. Cederholm; on 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 214 KB

Oral disease and subsequent cardiovascul

Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial

✍ Q. Li; J. Chalmers; S. Czernichow; B. Neal; B. A. Taylor; S. Zoungas; N. Poulter 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 145 KB